HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dexing Zeng Selected Research

Dexing Zeng Research Topics

Disease

23Neoplasms (Cancer)
12/2023 - 12/2010
5Neoplasm Metastasis (Metastasis)
01/2022 - 07/2017
4Breast Neoplasms (Breast Cancer)
04/2024 - 12/2010
3Melanoma (Melanoma, Malignant)
01/2020 - 01/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 07/2017
2Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 11/2014
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2017 - 11/2014
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Inflammation (Inflammations)
01/2022
1Delayed Graft Function
01/2019
1Lung Neoplasms (Lung Cancer)
01/2018
1Chromosomal Instability (Chromosome Stability)
07/2017
1Carcinogenesis
07/2017
1Neoplasms, Cystic, Mucinous, and Serous
07/2017
1Carcinoma in Situ
07/2017
1Hepatocellular Carcinoma (Hepatoma)
01/2017
1Liver Neoplasms (Liver Cancer)
01/2017
1Prostatic Neoplasms (Prostate Cancer)
01/2016
1Carcinoma (Carcinomatosis)
01/2016
1Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2014

Drug/Important Bio-Agent (IBA)

5Peptides (Polypeptides)IBA
01/2022 - 03/2018
5LigandsIBA
01/2020 - 12/2010
5Chelating AgentsIBA
10/2018 - 11/2014
4IntegrinsIBA
12/2023 - 03/2018
4sigma-2 receptorIBA
01/2017 - 12/2010
3CD13 Antigens (Alanine Aminopeptidase)IBA
12/2023 - 01/2020
2N-(1,4,8,11- tetraazacyclotetradecanyl- 1,4- phenylenebis(methylene))- 2- (aminomethyl)- pyridineIBA
04/2024 - 07/2019
2Integrin alpha4beta1 (VLA-4)IBA
01/2020 - 10/2018
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 01/2016
11,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
12/2023
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022
1AntibodiesIBA
10/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Arginine (L-Arginine)FDA Link
01/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2020
1asparagine-glycine-arginineIBA
01/2020
1UbiquitinIBA
07/2019
1phosphonic acidIBA
10/2018
1Gallium-68IBA
10/2018
1Organophosphonates (Phosphonates)IBA
03/2018
1Analgesics (Analgesic Drugs)IBA
01/2018
1N- (4- amino- 2- methylquinolin- 6- yl)- 2- (4- ethylphenoxymethyl)benzamideIBA
01/2018
1Carbonic Anhydrase IXIBA
01/2018
1MicellesIBA
01/2018
1PolymersIBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Therapeutic UsesIBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
07/2017
1HMGB1 Protein (HMG1)IBA
07/2017
1Receptor for Advanced Glycation End ProductsIBA
07/2017
1Glycyrrhizic Acid (Glycyrrhizin)IBA
07/2017
1Nucleosomes (Nucleosome)IBA
07/2017
1Neutralizing AntibodiesIBA
07/2017
1Histones (Histone)IBA
07/2017
1B7-H1 AntigenIBA
01/2017
1Radioisotopes (Radionuclides)IBA
01/2017
1YttriumIBA
01/2017
1Monoclonal AntibodiesIBA
01/2017
1Sunitinib (Sutent)FDA Link
01/2017
1RadiopharmaceuticalsIBA
07/2016
1AntigensIBA
01/2016
1phosphoramidic acidIBA
01/2016
1ErbB Receptors (EGF Receptor)IBA
11/2014
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2014
1Cetuximab (Erbitux)FDA Link
11/2014
1Copper-64IBA
11/2014
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
07/2014
1Somatostatin Receptors (Somatostatin Receptor)IBA
07/2014
1Iodine-125IBA
12/2010
1Fluorine-18IBA
12/2010

Therapy/Procedure

5Therapeutics
01/2018 - 07/2011
2Immunotherapy
01/2021 - 01/2017
1Ligation
10/2021
1Radiofrequency Ablation
01/2020
1Kidney Transplantation
01/2019
1Oral Administration
01/2018
1Radiotherapy
01/2017